Business Description
ChromoGenics AB
ISIN : SE0020847481
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.21 | |||||
Debt-to-Equity | 2.32 | |||||
Debt-to-EBITDA | -2.24 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -8.2 | |||||
Beneish M-Score | -2.39 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -69.6 | |||||
3-Year EBITDA Growth Rate | 62.2 | |||||
3-Year EPS without NRI Growth Rate | 60.5 | |||||
3-Year FCF Growth Rate | 67.6 | |||||
3-Year Book Growth Rate | -51.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 83.35 | |||||
9-Day RSI | 77.63 | |||||
14-Day RSI | 72.68 | |||||
6-1 Month Momentum % | 33.46 | |||||
12-1 Month Momentum % | -29.05 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.75 | |||||
Quick Ratio | 0.46 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 1690.75 | |||||
Days Sales Outstanding | 171.28 | |||||
Days Payable | 852.44 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -142.5 | |||||
Shareholder Yield % | -34.22 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 69.89 | |||||
Operating Margin % | -405.79 | |||||
Net Margin % | -444.76 | |||||
FCF Margin % | -366.87 | |||||
ROE % | -71.91 | |||||
ROA % | -24.59 | |||||
ROIC % | -24.54 | |||||
ROC (Joel Greenblatt) % | -32.75 | |||||
ROCE % | -27.54 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.61 | |||||
PB Ratio | 1.39 | |||||
Price-to-Tangible-Book | 2.16 | |||||
EV-to-EBIT | -3.95 | |||||
EV-to-EBITDA | -4.31 | |||||
EV-to-Revenue | 15.92 | |||||
EV-to-FCF | -4.34 | |||||
Earnings Yield (Greenblatt) % | -25.32 | |||||
FCF Yield % | -46.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
ChromoGenics AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 8.19 | ||
EPS (TTM) (kr) | -15.61 | ||
Beta | 0 | ||
Volatility % | 69.31 | ||
14-Day RSI | 72.68 | ||
14-Day ATR (kr) | 0.589386 | ||
20-Day SMA (kr) | 7.331 | ||
12-1 Month Momentum % | -29.05 | ||
52-Week Range (kr) | 3.86 - 16 | ||
Shares Outstanding (Mil) | 6.63 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ChromoGenics AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ChromoGenics AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
ChromoGenics AB Frequently Asked Questions
What is ChromoGenics AB(OSTO:CHRO)'s stock price today?
When is next earnings date of ChromoGenics AB(OSTO:CHRO)?
Does ChromoGenics AB(OSTO:CHRO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |